NCT03578367
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03578367
Title Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | GBR | FRA | ESP | DNK | DEU | CZE | CAN | AUT

Facility Status City State Zip Country Details
Georgia Regents University Augusta Georgia 30912 United States Details
Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21205 United States Details
Novartis Investigative Site Vienna 1140 Austria Details
Novartis Investigative Site Montreal Quebec H1T 2M4 Canada Details
Novartis Investigative Site Brno 625 00 Czechia Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Krakow 31 531 Poland Details
Novartis Investigative Site Warsaw 00-791 Poland Details
Novartis Investigative Site Wroclaw 50 367 Poland Details
Novartis Investigative Site Lisbon 1099-023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Moscow 125167 Russia Details
Novartis Investigative Site Moscow 125284 Russia Details
Novartis Investigative Site Saint Petersburg 191024 Russia Details
Novartis Investigative Site Saint Petersburg 197341 Russia Details
Novartis Investigative Site Uijeongbu-si Gyeonggi-do 11759 South Korea Details
Novartis Investigative Site Seoul Seocho Gu 06591 South Korea Details
Novartis Investigative Site Seville Andalusia 41009 Spain Details
Novartis Investigative Site Badalona Catalonia 08916 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Changhua 50006 Taiwan Details
Novartis Investigative Site Taoyuan District 33305 Taiwan Details
Novartis Investigative Site Liverpool CH63 4JY United Kingdom Details
Novartis Investigative Site London W12 0HS United Kingdom Details
Novartis Investigative Site Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field